DBV TECHNOLOGIES S A

Historical 13F Holders

Symbol
DBVT
CUSIP
23306J309
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 23306J309 since 12/18/2024, newest first.

Filer % of Class Filed
MPM BioImpact LLC 13G/A Amendment 2 6.2% 8/14/2026
Event 6/30/2026
RA Capital Management, L.P. 13G
5.8% 8/6/2026
Event 7/30/2026
MPM BioImpact LLC 13G/A Amendment 1 8.8% 5/15/2026
Event 3/31/2026
Artisan Partners Limited Partnership 13G/A Amendment 1
3.7% 5/13/2026
Event 3/31/2026
Adage Capital Management, L.P. 13G/A Amendment 1
7.3% 5/13/2026
Event 3/31/2026
Vivo Opportunity Fund Holdings, L.P. 13G/A Amendment 2
4.0% 5/12/2026
Event 3/31/2026
Invus Global Management, LLC 13G/A Amendment 2
6.5% 5/5/2026
Event 3/31/2026
MPM BioImpact LLC 13G 9.9% 2/17/2026
Event 12/31/2025
Venrock Healthcare Capital Partners II, L.P. 13G/A Amendment 5
0% 2/17/2026
Event 12/31/2025
Invus Global Management, LLC 13G/A Amendment 1
6.2% 2/13/2026
Event 12/31/2025
Vivo Opportunity Fund Holdings, L.P. 13G/A Amendment 1
5.7% 2/13/2026
Event 1/12/2026
Artisan Partners Limited Partnership 13G
7.0% 2/3/2026
Event 12/31/2025
Baker Bros. Advisors LP 13D/A Amendment 9
10.0% 1/14/2026
Event 1/12/2026
Bpifrance Participations SA 13D/A Amendment 10
4.7% 1/7/2026
Event 1/5/2026
Bpifrance Participations SA 13D/A Amendment 9
5.3% 1/5/2026
Event 12/31/2025
Bpifrance Participations SA 13D/A Amendment 8
6.8% 12/19/2025
Event 12/17/2025
Venrock Healthcare Capital Partners II, L.P. 13G/A Amendment 4
8.2% 11/14/2025
Event 9/30/2025
Bpifrance Participations SA 13D/A Amendment 7
9.4% 11/4/2025
Event 10/31/2025
Invus Global Management, LLC 13G
7.8% 10/14/2025
Event 10/6/2025
Venrock Healthcare Capital Partners II, L.P. 13G/A Amendment 3
9.8% 8/14/2025
Event 6/30/2025
Adage Capital Management, L.P. 13G
10.0% 8/12/2025
Event 6/30/2025
Citadel Advisors LLC 13G
6.4% 4/14/2025
Event 4/7/2025
Suvretta Capital Management, LLC 13G
9.9% 4/11/2025
Event 4/7/2025
Vivo Opportunity Fund Holdings, L.P. 13G
10.0% 4/8/2025
Event 4/7/2025
Bpifrance Participations SA 13D/A Amendment 6
12.2% 4/7/2025
Event 3/27/2025
Baker Bros. Advisors LP 13D/A Amendment 8
17.1% 3/31/2025
Event 3/27/2025
Braidwell LP 13G/A Amendment 3
2.5% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 2.61 k $30.7 k
2026 Q2 78 21.5 M $346 M
2026 Q1 72 21.2 M $434 M
2025 Q4 52 16.2 M $302 M
2025 Q3 34 6.52 M $65.2 M
2025 Q2 30 7.23 M $66.2 M
2025 Q1 17 2.47 M $16.8 M
2024 Q4 19 2.74 M $8.46 M